Clinical trials
Phase 2/3 Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eyetech Pharmaceuticals | 3 |
| EyeBiotech Ltd. | 2 |
| AbbVie | 1 |
| Alkeus Pharmaceuticals, Inc. | 1 |
| Asociación para Evitar la Ceguera en México | 1 |
| Canadian Retinal Trials Group | 1 |
| East Florida Eye Institute | 1 |
| Janssen Research & Development, LLC | 1 |
| Johns Hopkins University | 1 |
| Kaplan Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 27 |
| Choroidal Neovascularization | 7 |
| Wet Macular Degeneration | 7 |
| Geographic Atrophy | 3 |
| Retinal Diseases | 3 |
| Eye Diseases | 2 |
| Retinal Degeneration | 2 |
| Choroid Diseases | 1 |
| Glaucoma | 1 |
| Melanoma | 1 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.